No pain is gain: A prospective evaluation of strict non-opioid pain control after pediatric appendectomy.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 03 02 2020
accepted: 20 02 2020
pubmed: 17 3 2020
medline: 3 11 2020
entrez: 16 3 2020
Statut: ppublish

Résumé

Opiates are often prescribed after pediatric operations despite safety concerns and lack of evidence confirming superiority compared to other pain control modalities. In this study, we use daily parental surveys to prospectively evaluate a strict non-opioid pain control strategy after laparoscopic appendectomy. After IRB approval, children who underwent laparoscopic appendectomy for nonperforated acute appendicitis were recruited to the study. For these patients, our standard practice is to provide instructions to administer alternating acetaminophen and ibuprofen over-the-counter (OTC) postoperatively, and no opiate prescriptions are written. Parents of enrolled children received a daily RedCap survey via text message or e-mail on postoperative days (POD) 1 through 5 to prospectively assess pain control and medication usage. Trends were compared across postoperative days. One hundred twenty patients were enrolled in the study, and none received opiate prescriptions. Postoperative pain survey response rates were 54% on POD1, 47% on POD2, 35% on POD3, 34% on POD4, and 29% on POD5. Pain level was 4.7 ± 2.3 (out of 10) on POD1, and down-trended significantly each postoperative day to reach 0.7 ± 1.2 by POD5. On POD1, 85% of parents administered OTC medications, which reduced significantly to 14% by POD5. Parent-reported success rates to manage pain by OTC regimen were 85% on POD1, 94% on POD2, 91% on POD3, and 100% on POD4 and POD5. Strict non-opioid pain control after appendectomy exhibits high performance based upon prospective parental surveys. This strategy should be implemented as standard of care and tested for application to other surgical conditions. Level II.

Identifiants

pubmed: 32171535
pii: S0022-3468(20)30182-2
doi: 10.1016/j.jpedsurg.2020.02.051
pii:
doi:

Substances chimiques

Analgesics, Non-Narcotic 0
Analgesics, Opioid 0
Acetaminophen 362O9ITL9D
Ibuprofen WK2XYI10QM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1043-1047

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Kristin M Gee (KM)

Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Electronic address: Kristin.m.gee@gmail.com.

R Ellen Jones (RE)

Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.

Nicole Nevarez (N)

Department of Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.

Lauren E McClain (LE)

Children's Health, 1935 Medical District Dr., Dallas, TX 75235.

Gentry Wools (G)

Children's Health, 1935 Medical District Dr., Dallas, TX 75235.

Alana L Beres (AL)

Department of Surgery, UC Davis Children's Hospital, 2315 Stockton Blvd., Sacramento, CA 95817.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH